AI-Powered Insights Extended to the Point of Care
The Prospective Risk Adjustment solution delivers timely, evidence-based AI-powered insights that directly impact member outcomes.
The Prospective Risk Adjustment solution delivers timely, evidence-based AI-powered insights that directly impact member outcomes.
The Association for Molecular Pathology has published consensus recommendations to aid in the design and validation of clinical CYP3A4 and CYP3A5 genotyping assays and promote standardization of testing.
Quality controls with lower cardiac troponin concentrations are needed to monitor and validate hs-cTn assay performance.
PCR Biosystems has launched a new family of qPCR reagents mixes: Clara Probe Mix, Clara Probe 1-Step Mix and Clara HRM Mix.
Verichem now offers customers free access to the its web-based and online calibration verification data reduction and test reporting programs.
Revvity's EuroImmun business has launched the UNIQO 160 automated indirect immunofluorescence test (IIFT) system for autoimmune disease diagnostics.
Yamaha Motor established a new medical company that will analyze the antibodies in blood to better visualize people's health conditions.
Sensaphone monitoring systems help laboratory staff maintain safe conditions and equipment by tracking and recording key data points.
Baker unveiled its Class II Type A2 biological safety cabinet, the SterilGARD e3, designed to be reliable, durable, and energy-efficient.
Research led by scientists in Brazil found that the coronavirus that causes COVID can be detected in tears collected by swabbing.